Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026)

Rigel Pharmaceuticals' Change in Inventory history runs 9 years deep, the most recent figure standing at $581000.0 for Q1 2026.

• On a quarterly basis, Change in Inventory rose 141.12% year-over-year to $581000.0 in Q1 2026; TTM through Mar 2026 was $7.6 million, a 270.02% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 837.57% from the prior year.
• Change in Inventory rose to $581000.0 in Q1 2026 per RIGL's latest filing, from -$1.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $8.4 million in Q2 2025 and bottomed at -$3.3 million in Q3 2024.
• The 5-year median for Change in Inventory is -$188000.0 (2025), against an average of $391588.2.
• Across the five-year window, Change in Inventory surged 1640.18% in 2023 and plunged 1090.04% in 2024, its largest moves.
• Year by year, Change in Inventory stood at $2.0 million in 2022, then slumped by 227.63% to -$2.5 million in 2023, then rose by 23.94% to -$1.9 million in 2024, then surged by 41.25% to -$1.1 million in 2025, then soared by 151.37% to $581000.0 in 2026.
• Per Business Quant, the three latest RIGL Change in Inventory figures stand at $581000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$188000.0 (Q3 2025).